Intratumoral/Intralesional Administration of MK-4621/JetPEI™ With or Without Pembrolizumab in Participants With Advanced/Metastatic or Recurrent Solid Tumors (MK-4621-002)
Clinical trial NCT03739138 · TERMINATED
Trial details
- NCT number
- NCT03739138
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-18
- Primary completion
- 2021-03-02
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.